Hundreds of children in England are receiving prescriptions for GLP-1 medications, including some younger than 12, the Guardian can reveal.
asserted
Guardian → receive → 12
GLP-1 medications were initially developed to help people with type 2 diabetes control their blood sugar levels, but have since become a popular slimming aid, with products such as Wegovy and Mounjaro becoming household names.
asserted
products → develop → Wegovy
While social media is awash with adults who have lost weight with GLP-1s, data shows a number of children are also being prescribed them.
asserted
number → lose → them
A Guardian investigation has revealed that in the financial year 2025-26 there were 419 prescriptions issued to children under the age of 18, 10 of which were for children under the age of 12.
asserted
10 → reveal → 12
And in the four months from April to July this year, 341 prescriptions for GLP-1s were issued to children, 15 of whom were under the age of 12.
asserted
15 → issue → 12
The figures, obtained from the NHS Business Services Authority through freedom of information requests, relate to prescriptions in England and dispensed in a community setting anywhere in the UK.
asserted
figures → obtain → UK
However, they do not cover those prescribed and dispensed via private prescriptions, in prisons, and in hospitals, meaning the figures are likely to be a considerable underestimate.
asserted
figures → cover → hospitals
One private clinic for children has previously revealed it has more than 200 patients receiving the jabs.
asserted
it → reveal → jabs
It is also unclear whether the GLP-1 figures reflect medications that are being given primarily for weight loss.
uncertain
that → reflect → loss
Martin Whyte, a professor of metabolic medicine at the University of Surrey, said the number of prescriptions was still small relative to the scale of childhood obesity, but those taking the drugs needed long-term change to their lifestyles.
asserted
those → say → lifestyles
He said: “The important thing is that children who start them do so within specialist services, with support for diet, growth and wellbeing, and a plan for the long term.
asserted
who → say → term
“That includes regular monitoring of growth and puberty, nutritional intake, mental health and eating behaviours, and side effects.
asserted
That → include → growth
This matters partly because we know weight tends to return when the drugs are stopped, and partly because we still have limited data on use over many years in growing young people.
asserted
we → matter → people
The rising use of GLP-1s comes as levels of childhood obesity are increasing.
asserted
levels → rise → obesity
Figures from the National Child Measurement Programme show that 10.7% of reception-year children (ages 4 and 5) are obese, while that rises to 22.8% for children in year 6 (ages 10 and 11).
asserted
that → show → year
According to the World Health Organization (WHO), 400 million children and adolescents aged between five and 19 were overweight in 2024, including 170 million living with obesity.
uncertain
children → accord → obesity
As part of efforts for early intervention, the NHS began piloting Complications from Excess Weight (CEW) clinics from 2021, aimed at children aged two to 16 with severe obesity.
asserted
NHS → begin → obesity
In May, NHS England revealed almost 6,500 children have since been referred to such clinics, including more than 400 younger than four.
uncertain
children → reveal → four
Hundreds of young people have received weight-loss medications through such services – although only some CEW clinics can access funding to offer GLP-1s, and these are typically dispensed through hospital pharmacies.
asserted
these → receive → pharmacies
Dr Dunia Ismail, a consultant paediatrician who runs a CEW clinic, said experts were now looking at widening the use of GLP-1s in such settings.
asserted
experts → run → settings
“We have been sticking to 12 [years], although now we are looking at expanding that to eight-plus once licence-approved,” she said.
asserted
she → stick → plus
Last month, new global guidelines from the WHO stated obesity medications, including GLP-1s, should not be given to children under the age of 10.
asserted
medications → state → 10
However, recent data from a trial involving 165 children aged 6 to under 12 – run by the pharmaceutical company Novo Nordisk, which produces Wegovy and Victoza – has suggested GLP-1s can help young children with obesity.
uncertain
GLP-1s → involve → obesity
Julian Hamilton-Shield, a professor in diabetes and metabolic endocrinology and a clinician at the Bristol Complications CEW clinic, said typically children who receive semaglutide at CEW clinics had been unable to lose weight through standard dietary and nutritional advice and psychological support.
asserted
who → say → advice
“Probably, in the vast majority of cases, they have a secondary comorbidity such as type 2 diabetes, obstructive sleep apnoea, liver disease, intracranial hypertension – you name it, they’ve got it,” he said.
asserted
he → have → it
“So it’s been used as an adjunct after standard therapies haven’t really helped.
asserted
therapies → use → adjunct
However, it is used quite frequently and it is a very effective drug.”
asserted
it → use → ?
Hamilton-Shield stressed GLP-1 medications were given to children who have very high excess weight.
asserted
who → stress → weight
“You’d call it morbid obesity if you were classifying it as adults,” he said.
asserted
he → call → adults
The use of GLP-1s in children has reignited a debate about the drivers of childhood obesity, but experts say it is important to avoid blaming patients or their families.
asserted
it → reignite → patients
“We’re a health service that delivers health to the people who require it.
asserted
who → ’re → it
We’re not one that makes moral judgments about people,” said Hamilton-Shield.
asserted
Shield → ’re → people
“Nobody’s saying that every child who’s a bit heavy should have a GLP-1.”
asserted
who → say → GLP-1
Hamilton-Shield added: “These children and young people are from very complex backgrounds, have enormous lack of self-esteem.
asserted
children → add → esteem
They’re not attending school.
asserted
They → attend → school
They’ve got all these complications.
asserted
They → get → complications
They’ve got all the stigma.
asserted
They → get → stigma
And when you actually give them a drug that helps them to lose maybe 25, 30kg, [it is] the first time they feel they have any agency in their lives at all, and that will have a transformative effect in its own right.”
asserted
that → give → right
Ismail also stressed the importance of GLP-1s for children.
asserted
Ismail → stress → children
“We know now that obesity is not a choice, it’s a condition,” she said.
asserted
she → know → ?
…and 3 more, not listed.